Claus Roehrborn - Concepedia

Author

Claus Roehrborn

The University of Texas Southwestern Medical Center

Also Known As

C. Roehrborn, Claus G Roehrborn, Claus Roehrborn, Claus Roehrborn*, Edmund Infertility, M Boston, Mi Arbor, R Yu

103

Publications

748

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Albany Medical Center Hospital Los Angeles Clinical Trials University of Toronto

About

Claus Roehrborn is an author at The University of Texas Southwestern Medical Center specializing in medicine, urology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	168
2	Endocrinology	2	2	75
3	Epidemiology	1	1	17
4	Immunology	1	1	17
5	Pathology	1	1	17

Claus Roehrborn

Publications

478

Citations

H-Index

Page 1

	Year	Citations
Robot-Assisted Versus Open Simple Prostatectomy for Benign Prostatic Hyperplasia in Large Glands: A Propensity Score–Matched Comparison of Perioperative and Short-Term Outcomes Igor Sorokin, Varun Sundaram, Nirmish Singla, Journal of Endourology	2017	92
WATER II (80–150 mL) procedural outcomes Mihir Desai, Mo Bidair, Naeem Bhojani, British Journal of Urology	2018	84
5-Alpha Reductase Inhibition Provides Superior Benefits to Alpha Blockade by Preventing AUR and BPH-Related Surgery Peter Boyle, Claus Roehrborn, Richard C. Harkaway, European Urology MedicineBph-related SurgeryAlpha BlockadePharmacotherapyEndocrinology	2003	60
Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results Naeem Bhojani, Mo Bidair, Eugene V. Kramolowsky, The Journal of Urology	2023	47
Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial. Peter Gilling, Neil Barber, Mohamed Bidair, PubMed	2020	45
RESULTS OF THE PREDICT (PROSPECTIVE EUROPEAN DOXAZOSIN AND COMBINATION THERAPY) TRIAL Roger Kirby, Jens E. Altwein, Georg Bartsch, The Journal of Urology The PredictMedicineClinical TrialsPharmacotherapyDrug Trial	1999	28
Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study Steve Kaplan, Ronald P. Kaufman, Thomas Mueller, Prostate Cancer and Prostatic Diseases	2023	27
THE EFFICACY AND SAFETY OF TADALAFIL ADMINISTERED ONCE A DAY FOR LOWER URINARY TRACT SYMPTOMS (LUTS) IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH) K. Mc Vary, Claus Roehrborn, Jed Kaminetsky, European Urology Supplements UrologyMedicineBenign Prostatic HyperplasiaUrogynecologyPharmacotherapy	2006	20
How I do it: Balloon tamponade of prostatic fossa following Aquablation. Nikolai Aljuri, Peter Gilling, Claus Roehrborn PubMed UrologyMinimally Invasive ProcedureProstate TissueBalloon TamponadeBalloon Catheter	2017	18
10 The impact of acute or chronic inflammation in baseline biopsy on the risk of progression in the MTOPS study Claus Roehrborn European Urology Supplements InflammationRheumatologyPrognostic BiomarkersDisease ProgressionImmunology	2005	17

Page 1